Human abuse potential (HAP) studies are conducted to determine the potential abuse of a drug that has rewarding properties. Abuse potential refers to the likelihood for a drug to be used in nonmedical situations for its positive psychoactive effects, eg, euphoria, hallucinations and mood changes. This poster considers subject selection and a study conducted by PRA Health Sciences to assess whether there were common cognitive and psychological characteristics of subjects who passed or failed the discrimination phase of a HAP study.
Central Review Services
PRA's Central Review Services team, unique in the CRO industry, offers lupus-specific expertise in efficacy endpoint data correlation, standardized…
Pharmacogenomics in Pain Management
Pharmacogenomics in Pain Management. In the US alone there are an estimated 100 million adults suffering from chronic pain. Pharmacogenomics and…
Successes in Phase II Autologous Cellular Therapy Oncology Program
A case study describing two Phase II, multicenter studies assessing the efficacy and safety of an autologous cellular therapy treatment.